Holdings of Foresite Capital Management V, LLC
8 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 8 | 265.5M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Alumis Inc | 5,896,995 | 129.9M $ | |
| 2 | CG oncology Inc | 1,004,050 | 68M $ | |
| 3 | Disc Medicine Inc | 374,069 | 23.9M $ | |
| 4 | Hims & Hers Health Inc | 738,151 | 15.3M $ | |
| 5 | Eikon Therapeutics Inc | 1,318,983 | 14M $ | |
| 6 | Lyell Immunopharma Inc | 477,078 | 9.6M $ | |
| 7 | Nurix Therapeutics Inc | 265,000 | 4.1M $ | |
| 8 | Maze Therapeutics Inc | 25,905 | 773.3K $ |